Congestive Heart Failure (CHF) and Cor Pulmonale

🔍 Definition

Congestive Heart Failure (CHF) is a clinical syndrome in which the heart is unable to pump sufficient blood to meet the body’s metabolic demands, or can do so only at elevated filling pressures. Per the ACC/AHA Heart Failure Guidelines, CHF encompasses a spectrum of structural and functional abnormalities causing symptoms of dyspnea, fatigue, and fluid retention.

Heart failure is classified by left ventricular ejection fraction (LVEF):

  • HFrEF (Heart Failure with reduced EF): LVEF < 40% — systolic dysfunction, impaired contractility.
  • HFpEF (Heart Failure with preserved EF): LVEF ≥ 50% — diastolic dysfunction, impaired relaxation and filling.
  • HFmrEF (Heart Failure with mildly reduced EF): LVEF 41–49% — a transitional phenotype gaining clinical recognition.
  • HFimpEF (Heart Failure with improved EF): Previously reduced EF now ≥ 40% on treatment. Per AHA Coding Clinic, code based on the current documented EF state, not the historical nadir.

Cor Pulmonale is right heart failure (RHF) caused by pulmonary hypertension from primary pulmonary disease — most commonly COPD, pulmonary fibrosis, or pulmonary arterial hypertension. Acute cor pulmonale is classically triggered by massive pulmonary embolism causing acute right ventricular pressure overload. Chronic cor pulmonale results from sustained pulmonary hypertension, leading to right ventricular hypertrophy and eventual right heart failure. See CMS FY2026 ICD-10-CM Tabular for current code assignments.

Stages of HF (ACC/AHA):

  • Stage A: At risk for HF, no structural disease or symptoms
  • Stage B: Structural heart disease, no HF symptoms
  • Stage C: Structural disease + prior or current HF symptoms
  • Stage D: Refractory/end-stage HF requiring advanced therapies (maps to I50.84)

NYHA Functional Classification (Class I–IV) documents functional limitation severity and supports CDI for acuity determination.

🗂️ Alternative Terminology

The following table cross-maps clinical, lay, and documentation terminology to ICD-10-CM codes, enabling coders to recognize non-standard documentation that still warrants specific code assignment.

Formal / ICD-10-CM TermColloquial / Lay / Clinical SynonymsKey Coding Note
Systolic HF (HFrEF)Low EF heart failure, pump failure, systolic dysfunctionRequires LVEF < 40% documentation; maps to I50.2x
Diastolic HF (HFpEF)Preserved EF HF, stiff heart, diastolic dysfunction with symptomsRequires LVEF ≥ 50% with HF symptoms; maps to I50.3x
Combined systolic + diastolic HFMixed HF, HFmrEF with both patternsMaps to I50.4x when both explicitly documented
Right heart failure, isolatedRight-sided HF, RV failure, right ventricular failureMaps to I50.81x series; distinguish from cor pulmonale
Biventricular failureBoth sides failing, global cardiac failureI50.82 — requires explicit “biventricular” documentation
High-output HFHyperkinetic HF, high-output cardiac failureI50.83 — causes include anemia, thyrotoxicosis, AV fistula
End-stage / Stage D HFRefractory HF, NYHA Class IV, advanced HFI50.84 — requires physician documentation of “end-stage”
HFimpEFRecovered EF, improved ejection fraction, HF with recovered EFCode based on current EF state per AHA Coding Clinic
Cor pulmonale, chronicCOPD heart failure, pulmonary heart disease, right HF from COPDI27.81 — HCC 226; requires underlying lung disease documentation
Cor pulmonale, acuteAcute right heart failure from PE, acute RV overloadI26.09 or I26.01 with the pulmonary embolism code
Congestive heart failureCHF, wet HF, volume overload, decompensated HFUnspecified without further detail → I50.9; query for specificity
Cardiogenic pulmonary edemaFlash pulmonary edema, acute decompensated HF with pulmonary edemaDo not assign J81.0 for pulmonary edema with heart failure; code the documented HF/left ventricular failure pathway (e.g., I50.1 or more specific I50.x when supported)
Hypertensive heart disease with HFHTN heart failure, hypertension causing CHFI11.0 — code first; add I50.x for HF type
Cardiorenal syndromeHF with AKI, HF with CKD worseningI13.x + I50.x + N18.x — complex sequencing rules apply
📝 Coder Note

The term “CHF” (congestive heart failure) is indexed to I50.9 (Heart failure, unspecified) in the ICD-10-CM Alphabetic Index. Always query for type (systolic/diastolic/combined) and acuity (acute/chronic/acute-on-chronic) when documentation uses only “CHF” without further specification. In V28, I50.9 already maps to HCC 226; the query improves accuracy, and documented acuity can change the HCC to 224 or 225, which CMS constrains to the same coefficient.

🩺 Signs & Symptoms

Heart failure presents with both left-sided and right-sided congestive symptoms. Documentation of specific signs supports acuity determination and distinguishes systolic from diastolic dysfunction.

Left-Sided HF (Pulmonary Congestion)

  • Dyspnea on exertion (DOE), orthopnea, paroxysmal nocturnal dyspnea (PND)
  • Pulmonary edema (cardiogenic) — crackles/rales on auscultation
  • S3 gallop (volume overload, systolic dysfunction) or S4 gallop (diastolic dysfunction, stiff LV)
  • Decreased exercise tolerance, fatigue, weakness
  • Pulsus alternans (severe systolic dysfunction)
  • BNP/NT-proBNP elevation (CPT 83880)

Right-Sided HF / Cor Pulmonale (Systemic Congestion)

  • Peripheral edema (bilateral pitting edema of lower extremities)
  • Jugular venous distension (JVD) / elevated JVP
  • Hepatomegaly, hepatojugular reflux
  • Ascites, pleural effusion (often right-sided or bilateral)
  • Right ventricular heave, loud P2 (pulmonary component of S2)
  • Cor pulmonale: cyanosis, signs of pulmonary hypertension (e.g., RV enlargement on echo)

Diagnostic Findings

  • Echocardiography: LVEF quantification (systolic vs. diastolic HF), wall motion abnormalities, RV enlargement, TR velocity for PA pressure estimation
  • Chest X-ray: Cardiomegaly, Kerley B lines, cephalization, pulmonary vascular congestion, pleural effusions
  • ECG: LVH pattern, LBBB (associated with systolic HF), RV strain pattern (cor pulmonale), sinus tachycardia
  • Labs: BNP >100 pg/mL or NT-proBNP >300 pg/mL, elevated creatinine/BUN (cardiorenal), hyponatremia (dilutional), anemia
  • Hemodynamics: Elevated PCWP (>18 mmHg left HF), elevated RAP/RVSP (right HF, cor pulmonale)
⚠️ Common Pitfall

Isolated diastolic dysfunction on echo (E/A ratio, tissue Doppler) does not code as HFpEF without clinical symptoms of heart failure. Document “heart failure with preserved ejection fraction” explicitly in the assessment/plan. Diastolic dysfunction alone codes to I51.81 — which is NOT an HCC under v28.

🧭 Differential Diagnosis

ConditionDistinguishing FeaturesKey ICD-10-CM Code
Cardiac tamponadeBeck’s triad (hypotension, JVD, muffled heart sounds); pulsus paradoxus; Echo: pericardial effusion with RV collapseI31.4
COPD exacerbationObstructive pattern on PFTs, hyperinflation on CXR, bronchodilator response, low BNP; may coexist with cor pulmonaleJ44.1
Pulmonary embolism (PE)Acute RV strain, D-dimer elevation, Wells score, CT-PA; acute cor pulmonale from PE → I26.0xI26.09, I26.01
PneumoniaFever, focal consolidation, productive cough, leukocytosis; BNP usually normalJ18.9 or organism-specific
Cirrhotic ascites / hepatic congestionLiver disease history, low albumin, elevated LFTs; ascites without elevated BNPK74.60 + R18.0
Nephrotic syndromeMassive proteinuria, hypoalbuminemia, edema; no pulmonary congestion, normal BNPN04.x
Constrictive pericarditisPericardial calcification on imaging, equalization of diastolic pressures on cath, Kussmaul signI31.1
Pulmonary arterial hypertension (PAH)RHC required for diagnosis; current hemodynamic definition requires mPAP >20 mmHg at rest with PAWP ≤15 mmHg and PVR >2 Wood units for pre-capillary/PAH physiology; may cause chronic cor pulmonaleI27.0
Severe anemiaHigh-output HF pattern; pallor, fatigue, elevated CO on echo, low hemoglobin; maps to I50.83 if HF documentedD64.9 + I50.83
Acute MI with HFTroponin elevation, ECG changes; HF as complication of MI codes under I21.x + I50.xI21.x + I50.x

📋 Clinical Indicators

The following indicators prompt coders and CDI specialists to identify whether a more specific HF code is supported by clinical documentation:

Clinical IndicatorDocumentation NeededCode Impact
Echocardiogram with LVEF < 40%Provider states “systolic HF” or “HFrEF” in assessmentI50.2x vs I50.9 — both HCC 226 unless acute (225) or acute on chronic (224)
Echocardiogram with LVEF ≥ 50% + HF symptomsProvider states “diastolic HF” or “HFpEF” in assessmentI50.3x vs I50.9 — same rule as systolic HF
Acuity: acute decompensation, admission for HF“Acute,” “acute on chronic,” or “decompensated” HF in assessmentHCC 225 (acute) or 224 (acute on chronic) vs HCC 226 (chronic); one constrained coefficient
Hypertension + HF in same patientCausal relationship is presumed when HTN and HF are documented unless the provider clearly states they are unrelatedI11.0 + additional I50.x code required (not I10 + I50.x)
CKD + HF + HTNAll three conditions with causal linkage documentedI13.x + I50.x + N18.x — combination code mandatory
COPD/pulmonary disease + right HF“Cor pulmonale” stated; pulmonary etiology documentedI27.81 (HCC 226) vs I50.81x (HCC 225 or 226 by acuity)
RV enlargement/failure from PE“Acute cor pulmonale” stated with PE documentationI26.01 (saddle PE w/ cor pulmonale) or I26.09 + cor pulmonale
End-stage HF / Stage D / NYHA IV refractoryProvider explicitly documents “end-stage,” “Stage D,” or “refractory heart failure”I50.84 — HCC 222 (End-Stage Heart Failure)
Previously low EF now improved (HFimpEF)Current LVEF documented ≥ 40%; physician documents current EF stateCode current EF state; if now diastolic HF, use I50.3x
Right HF with EF documentationRHF with documented EF status and etiology notedUse supported FY2027 right-HF/biventricular codes (I50.810–I50.814 or I50.82) as documented; do not assign unsupported I50.A1x/I50.A2x right-HF EF codes
💬 CDI Query Trigger

When the assessment documents “CHF” without specifying type or acuity, and the chart contains an echocardiogram report with a documented LVEF, the CDI specialist should query the treating physician to (a) confirm whether the HF is systolic or diastolic based on the echo findings, and (b) clarify whether the patient’s current presentation is acute, chronic, or acute-on-chronic. This clarification supports accurate code assignment; in V28 it can change the HCC among 224, 225, and 226, which share one coefficient.

🦴 Anatomy & Pathophysiology

Left Ventricular Failure

In systolic (HFrEF), cardiomyocyte loss (post-MI, dilated cardiomyopathy, myocarditis) reduces contractile force. Compensatory mechanisms — neurohormonal activation (RAAS, sympathetic), ventricular remodeling (hypertrophy, dilation) — initially maintain output but ultimately worsen dysfunction. Elevated left-sided filling pressures transmit retrograde to the pulmonary circulation, causing pulmonary venous hypertension and alveolar edema. Key references: 2022 AHA/ACC/HFSA Heart Failure Guideline.

In diastolic (HFpEF), the LV is hypertrophied and noncompliant. Impaired relaxation (lusitropy) and reduced compliance elevate diastolic filling pressures despite preserved systolic function. Common in elderly women with hypertension, obesity, and diabetes. Metabolic inflammation and microvascular dysfunction play central roles per recent pathophysiology research.

Right Ventricular Failure and Cor Pulmonale

The RV is a thin-walled, crescent-shaped chamber optimized for high-volume, low-pressure work. Unlike the LV, the RV is exquisitely sensitive to acute afterload increases. In acute cor pulmonale (typically massive PE), sudden RV pressure overload causes RV dilation, interventricular septal shift (“D-sign” on echo), decreased LV preload, and rapid hemodynamic collapse. In chronic cor pulmonale, sustained pulmonary hypertension from parenchymal lung disease (COPD, ILD) drives progressive RV hypertrophy, eventually leading to RV dilation and tricuspid regurgitation.

Neurohormonal Axis

Reduced cardiac output activates the renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system, and arginine vasopressin (AVP) release. These mechanisms promote sodium and water retention (volume overload), vasoconstriction (increased afterload), and maladaptive cardiac remodeling. BNP and NT-proBNP are released in response to myocardial wall stress and serve as biomarkers of HF severity and therapeutic response.

Cardiorenal Syndrome (CRS)

In CRS Type 1 (acute HF → AKI), reduced renal perfusion from low cardiac output plus venous congestion elevates renal venous pressure and reduces GFR. In CRS Type 2 (chronic HF → CKD), chronic low output causes progressive nephron loss. When HF, HTN, and CKD coexist, combination codes I13.0 or I13.2 are required per ICD-10-CM Official Guidelines Section I.C.9.

💊 Medication Impact / Treatment

Pharmacologic management of HF directly impacts coding and CDI by establishing diagnoses (e.g., sacubitril/valsartan use confirms HFrEF) and indicating severity (e.g., IV inotropes suggest acute/end-stage HF).

Guideline-Directed Medical Therapy (GDMT) for HFrEF

  • ACE inhibitors / ARBs (e.g., lisinopril, losartan): Reduce afterload, reverse remodeling. Use in HFrEF (I50.2x).
  • ARNI — Sacubitril/Valsartan (Entresto): Superior to ACE inhibitor monotherapy in HFrEF. Covered under Medicare Part D. HCPCS J3490 (unclassified) or NDC-level billing. Presence on medication list strongly implies HFrEF (systolic HF).
  • Beta-blockers (carvedilol, metoprolol succinate, bisoprolol): Reduce mortality in HFrEF. May worsen acute decompensation.
  • Mineralocorticoid receptor antagonists (MRA) — spironolactone, eplerenone: Reduce mortality in HFrEF; use caution with CKD and hyperkalemia.
  • SGLT2 inhibitors (dapagliflozin/Farxiga, empagliflozin/Jardiance): Class I recommendation for symptomatic chronic HFrEF; Class IIa (“can be beneficial”) for HFmrEF/HFpEF per the 2022 AHA/ACC/HFSA guideline. Covered under Part D.
  • Vericiguat (Verquvo): sGC stimulator for high-risk HFrEF. Part D coverage. HCPCS unclassified (J3490 or equivalent).
  • Diuretics (furosemide, bumetanide, torsemide): Symptomatic relief of congestion. IV diuresis supports acute/decompensated HF coding.
  • Hydralazine/nitrates: Alternative to RAAS blockade; particularly in Black patients with HFrEF or when ACE/ARB contraindicated.
  • Ivabradine (Corlanor): HR reduction for HFrEF with sinus tachycardia on max-dose beta-blocker.
  • Digoxin: Older agent for symptom control in HFrEF with atrial fibrillation.

Acute / Inpatient HF Management (HCPCS-Billable Infusions)

  • Dobutamine (J1250): Positive inotrope for acute decompensated HFrEF; IV infusion. Supports acute HF diagnosis.
  • Milrinone (J1952): PDE-3 inhibitor inotrope/vasodilator for acute HF or bridge to transplant/LVAD.
  • Dopamine (J1265): Low-dose for renal perfusion; higher dose for cardiogenic shock.
  • Heparin (J1644): Anticoagulation in HF with AF, DVT/PE, or device-related thrombosis.
  • IV loop diuretics: Furosemide (J1940), bumetanide (J0395) for acute volume overload.
  • Nesiritide (Natrecor): BNP analog vasodilator; J2325.

Device and Advanced Therapies

  • ICD (Implantable Cardioverter-Defibrillator): Primary prevention in HFrEF with LVEF ≤ 35%. HCPCS C1721, C1722 for device components.
  • CRT-D (Cardiac Resynchronization Therapy with ICD): For HFrEF with LBBB; improves LVEF (may create HFimpEF). HCPCS C9604.
  • LVAD / VAD: Bridge to transplant or destination therapy for end-stage HF. CPT 33975–33983 for transthoracic/implantable VAD services and 33990–33998 for percutaneous/open arterial VAD services as applicable; HCPCS Q0478 (VAD component).
  • ECMO/ECLS: Temporary circulatory or respiratory support in cardiogenic shock or severe respiratory failure. Use the applicable initiation, cannulation/insertion, daily management, and removal codes (e.g., initiation 33946/33947; cannulation 33951–33956; removal 33965/33966/33969/33984–33986).
  • Impella: Percutaneous ventricular assist device. CPT 33990–33993.
  • Heart Transplant: Definitive therapy for refractory HF; postoperative status Z94.1.

Cor Pulmonale Treatment

Treatment targets the underlying pulmonary disease: bronchodilators and inhaled corticosteroids for COPD-related cor pulmonale; anticoagulation and embolectomy/thrombolytics for PE-associated acute cor pulmonale; pulmonary vasodilators (sildenafil, riociguat, prostacyclins) for PAH-related cor pulmonale.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, HCC v28 risk adjustment mapping, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines

Heart failure coding is governed by ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.9 (Diseases of the Circulatory System). Key rules for FY2026:

Guideline I.C.9.a — Hypertension with Heart Disease

A causal relationship between hypertension and heart failure is assumed when both are documented in the same record (unless the physician specifies a different cause). Therefore, when a patient has hypertension and heart failure:

  • Assign I11.0 (Hypertensive heart disease with heart failure) as the principal/first-listed code — NOT I10 (HTN alone) + I50.x separately.
  • Use an additional code from I50.x to specify the type of heart failure (e.g., I50.22 for chronic systolic HF).
  • If hypertension, heart disease, AND CKD are all present: use I13.0 (with stage 1–4 or unspecified CKD) or I13.2 (with stage 5 or ESRD), plus additional codes I50.x and N18.x.
🛡️ Audit Alert

Common audit finding: Coders assign I10 (Essential hypertension) + I50.9 (CHF unspecified) as two separate codes when both conditions are documented. Per ICD-10-CM Guideline I.C.9.a, the correct code is I11.0 (hypertensive heart disease with HF) as the combination code, plus the specific I50.x HF type. Failure to use I11.0 is a Top 10 OIG audit target for inpatient HF claims.

Guideline I.C.9.b — Hypertension with Heart Disease and CKD (I13.x)

When all three conditions (hypertension + heart disease + CKD) are present:

  • I13.0: Hypertensive heart and CKD with HF and CKD stages 1–4 or unspecified CKD. Use additional codes: I50.x (HF type) + N18.1–N18.4 or N18.9 (CKD stage).
  • I13.10: Hypertensive heart and CKD without HF, with CKD stages 1–4 or unspecified.
  • I13.2: Hypertensive heart and CKD with HF and CKD stage 5 or ESRD. Use additional I50.x + N18.5/N18.6 + Z99.2 if on dialysis.
  • Sequencing: I13.x is always listed first; I50.x and N18.x follow as additional codes. Never sequence I50.x before I13.x when the combination condition exists.

Guideline I.C.9.e — Acute Myocardial Infarction (AMI) with Subsequent HF

Heart failure arising after MI within the 4-week acute period codes with I21.x (AMI) as principal, with I50.x as secondary for HF as a complication. After 4 weeks, I22.x (subsequent MI) or late effects codes may apply.

Acute, Chronic, and Acute-on-Chronic HF

Per ICD-10-CM conventions and AHA Coding Clinic guidance, when both acute and chronic HF are documented for the same type:

  • Only one code is needed: the acute-on-chronic combination code (e.g., I50.23 for acute-on-chronic systolic HF).
  • Do not code both I50.21 (acute systolic) and I50.22 (chronic systolic) separately — use I50.23.
  • In V28, acute on chronic HF maps to HCC 224 and chronic HF to HCC 226; CMS constrained HCCs 224–226 to one coefficient.

Cor Pulmonale Coding Principles

  • Chronic cor pulmonale (I27.81): Assign when right heart failure is secondary to pulmonary hypertension caused by primary pulmonary disease (COPD, ILD, PAH). Code the underlying pulmonary condition additionally.
  • Acute cor pulmonale with PE (I26.01 or I26.09): Acute cor pulmonale is classified within the pulmonary embolism codes (I26.x). I26.01 = saddle embolus with acute cor pulmonale; I26.09 = other PE with acute cor pulmonale.
  • Do not confuse chronic cor pulmonale (I27.81) with isolated right HF (I50.81x). Cor pulmonale requires pulmonary hypertension from pulmonary disease as the etiology.

Right-Heart-Failure EF Documentation (FY2027)

For FY2027, do not assign an I50.A-series code for right heart failure with preserved or reduced EF. Code right heart failure using the supported right-HF/biventricular code pathway (I50.810–I50.814 or I50.82, as documented), and code systolic/diastolic/combined HF only when the provider documents those HF types.

  • These codes require documentation of both the right-sided HF AND the preserved or reduced EF status.

HFimpEF (Improved EF)

Per AHA Coding Clinic (see Section 13), when a patient previously had HFrEF but current LVEF has improved to ≥ 40% (or ≥ 50%), code based on the current documented EF state. If currently ≥ 50% with HF symptoms → I50.3x (diastolic/HFpEF). Always document the current LVEF to support the most appropriate code.

Rheumatic Heart Failure

I09.81 (Rheumatic heart failure) applies when rheumatic fever or rheumatic heart disease is the documented cause of HF. This is a separate etiology from hypertensive or ischemic HF. When rheumatic heart disease is the documented cause, assign I09.81 with an additional code for the type of heart failure (I50.-), per the Tabular List.

📝 Coder Note

Codes that are not heart failure HCCs in V28: I51.7 (Cardiomegaly), I51.81 (Takotsubo syndrome), and I51.89 (Other ill-defined heart diseases) map to no V28 payment HCC. I51.4 (Myocarditis, unspecified) and I51.5 (Myocardial degeneration) map to HCC 227 (Cardiomyopathy/Myocarditis), not to a heart failure HCC. These are commonly confused with HF codes. Always obtain clarification if only these codes appear in the HF patient’s chart.

🔢 ICD-10-CM Code Set (Tabular)

Heart Failure (I50.x) — Full Matrix (FY2027)

ICD-10-CM CodeDescriptionHCC v28Notes
I50.1Left ventricular failure, unspecifiedHCC 226Includes cardiac asthma; query for acuity
I50.20Unspecified systolic (congestive) heart failureHCC 226Query for acuity (acute/chronic/AoC)
I50.21Acute systolic (congestive) heart failureHCC 225Acute HF
I50.22Chronic systolic (congestive) heart failureHCC 226Stable, managed systolic HF
I50.23Acute on chronic systolic (congestive) heart failureHCC 224Most common inpatient admission code
I50.30Unspecified diastolic (congestive) heart failureHCC 226HFpEF unspecified acuity
I50.31Acute diastolic (congestive) heart failureHCC 225Acute HFpEF; flash pulmonary edema common presentation
I50.32Chronic diastolic (congestive) heart failureHCC 226Stable HFpEF, outpatient management
I50.33Acute on chronic diastolic (congestive) heart failureHCC 224Decompensated HFpEF
I50.40Unspecified combined systolic and diastolic heart failureHCC 226Both systolic + diastolic documented, acuity unspecified
I50.41Acute combined systolic and diastolic HFHCC 225Acute mixed presentation
I50.42Chronic combined systolic and diastolic HFHCC 226Stable combined HF
I50.43Acute on chronic combined systolic and diastolic HFHCC 224—
I50.810Right heart failure, unspecifiedHCC 226Distinguish from cor pulmonale (I27.81)
I50.811Acute right heart failureHCC 225Acute RHF not due to left HF or PE
I50.812Chronic right heart failureHCC 226Stable RHF
I50.813Acute on chronic right heart failureHCC 225Decompensated RHF
I50.814Right heart failure due to left heart failureHCC 226Biventricular with left cause; do not also code I50.82
I50.82Biventricular heart failureHCC 226Requires explicit “biventricular” documentation
I50.83High output heart failureHCC 226Anemia, thyrotoxicosis, AV fistula; high CO with HF symptoms
I50.84End-stage heart failureHCC 222Stage D; LVAD candidate, transplant candidate, or comfort care
I50.89Other heart failureHCC 226Not elsewhere classified
I50.9Heart failure, unspecifiedHCC 226“CHF” without type/acuity; always query for specificity

Cor Pulmonale and Related Codes

ICD-10-CM CodeDescriptionHCC v28Notes
I26.01Saddle embolus of pulmonary artery with acute cor pulmonaleHCC 267Massive PE; high mortality risk
I26.09Other pulmonary embolism with acute cor pulmonaleHCC 267Non-saddle PE with acute RV overload
I26.02Saddle embolus without acute cor pulmonaleHCC 267Saddle PE without RV failure
I26.90Pulmonary embolism, unspecified, without acute cor pulmonaleHCC 267Query for cor pulmonale if RV dysfunction documented
I27.0Primary pulmonary hypertensionHCC 226Idiopathic PAH; causes chronic cor pulmonale
I27.81Cor pulmonale (chronic)HCC 226RHF from pulmonary disease; code underlying condition additionally
I27.82Chronic pulmonary embolismHCC 267CTEPH; may cause chronic cor pulmonale; code I27.81 additionally if cor pulmonale present
I27.9Pulmonary heart disease, unspecifiedHCC 226Query for specific pulmonary heart disease diagnosis

Hypertensive Heart Failure Combination Codes

ICD-10-CM CodeDescriptionUse Additional CodeNotes
I11.0Hypertensive heart disease with heart failureI50.x (HF type)Code first when HTN + HF; assumed causal relationship
I13.0Hypertensive heart and CKD with HF, CKD stage 1–4 or unspecifiedI50.x + N18.1–N18.4 or N18.9All three conditions present
I13.2Hypertensive heart and CKD with HF, CKD stage 5 or ESRDI50.x + N18.5 or N18.6 + Z99.2 if dialysisAdd Z99.2 if on dialysis
I09.81Rheumatic heart failureI50.x (HF type)Rheumatic disease as etiology of HF; use additional code for HF type (I50.-)
⚠️ Common Pitfall

When a patient has hypertension, heart failure, AND CKD, coders must use I13.0 or I13.2 (not I11.0 + N18.x separately). Failure to use the I13.x combination code is a common DRG validation audit finding. Always verify all three conditions are documented before applying I13.x; the causal relationship is presumed (FY 2027 Guideline I.C.9.a.3).

🔎 Indexing

The following alphabetic index pathways guide correct code lookup in the ICD-10-CM Alphabetic Index:

Index EntrySubterms / QualifiersCode(s)
Failure, heart(congestive)I50.9
Failure, heartsystolic → see Failure, ventricular, left, systolicI50.20–I50.23
Failure, heartdiastolic → see Failure, ventricular, left, diastolicI50.30–I50.33
Failure, heartcombined systolic and diastolicI50.40–I50.43
Failure, heartright (secondary to left) → see Failure, heart, rightI50.810–I50.814
Failure, heartbiventricularI50.82
Failure, hearthigh outputI50.83
Failure, heartend stageI50.84
Cor pulmonale(chronic)I27.81
Cor pulmonaleacute → see Embolism, pulmonary, with cor pulmonaleI26.01 or I26.09
Disease, heart, hypertensivewith heart failureI11.0
Disease, heart, hypertensivewith CKD and HF → see Hypertension, heart and CKDI13.0, I13.2
CHF(see also Failure, heart, congestive)I50.9
Cardiomegaly—I51.7 (NOT HCC)
Diastolic dysfunctionalone (no HF symptoms)I51.81 (NOT HCC)
Failure, ventricular, rightacute on chronicI50.813
📝 Coder Note

“Congestive heart failure” indexed directly goes to I50.9. The coder must apply the full subterm pathway for systolic (I50.2x), diastolic (I50.3x), combined (I50.4x), or right HF (I50.81x) — these are NOT default index entries for “CHF.” Always review the complete visit documentation, including echocardiogram reports, and apply the most specific code supported by physician documentation.

🏥 CPT

The following CPT codes are relevant to the diagnosis, monitoring, and management of heart failure and cor pulmonale per the AMA CPT 2027 Manual:

CPT CodeDescriptionGlobalClinical Notes
83880Natriuretic peptide (BNP or NT-proBNP)N/A (lab)Quantitative serum biomarker; key HF diagnosis/monitoring test
93306Echocardiography, TTE with Doppler (complete)N/APrimary test for LVEF, wall motion, valvular disease; establishes HF type
93350Stress echocardiography (treadmill or bicycle)N/AIschemic etiology of HF; diastolic stress echo for HFpEF evaluation
93351Stress echo with Doppler and/or color flowN/AEnhanced stress echo with hemodynamic assessment
93355Transesophageal echo (TEE) with 3D reconstructionN/AValvular HF (MR, AR), pre-operative device assessment
93458Left heart catheterization000LVEF, PCWP, coronary artery evaluation in HF
93459Left heart cath with left ventriculography000Includes LV function assessment
93460Right and left heart catheterization000Full hemodynamic assessment; PAP, PCWP, CO for HF staging
93461Right and left heart cath with imaging000Comprehensive hemodynamic + angiographic
92920Percutaneous transluminal coronary angioplasty (PTCA), single vessel090PCI for ischemic HFrEF revascularization
92928PCI with stent, single vessel090Drug-eluting stent; ischemic HF revascularization
92944PCI, chronic total occlusion090CTO PCI for ischemic cardiomyopathy
33975LVAD insertion (extracorporeal)090Bridge to transplant or destination therapy in end-stage HF
33976LVAD insertion (intracorporeal)090Implantable LVAD (e.g., HeartMate 3, HVAD)
33977LVAD removal090Post-transplant or recovery
33983LVAD replacement of pump090Device exchange
33990Insertion of Impella (percutaneous LV assist device)000Cardiogenic shock, high-risk PCI support
33991Insertion of Impella with open cardiac procedure000Surgical Impella placement
33992Removal of Impella catheter000Separate procedure
33993Repositioning of Impella/percutaneous VAD catheter000Image-guided repositioning
33994Insertion of left heart VAD, open; axillary, subclavian, or innominate artery exposure with creation of conduit by infraclavicular or supraclavicular incision, unilateral000New CPT 2027 open arterial VAD-with-conduit insertion option
33996Insertion of left heart VAD, open; aorta exposure with creation of conduit by transthoracic incision000New CPT 2027 open aortic conduit VAD insertion option
33998Removal of left heart VAD with resection and stapling of graft conduit and skin closure000New CPT 2027 removal option for open arterial VAD conduit
33946ECMO/ECLS initiation, veno-arterialN/ACardiogenic shock, cardiac arrest; report cannulation and removal separately when separately reportable
33947ECMO/ECLS initiation, veno-venousN/ARespiratory failure with RHF/cor pulmonale; report cannulation and removal separately when separately reportable
93793Anticoagulation management (in-office, per 90 days)N/AHF patients on warfarin for AF, mechanical valves, or device thrombosis
99495Transitional Care Management (TCM), 14-day discharge contactN/AHF readmission reduction; moderate MDM
99496TCM, 7-day discharge contact, high medical decision complexityN/AHigh-complexity HF patients; face-to-face within 7 days
📝 Coder Note

NT-proBNP vs BNP: Both are reported with CPT 83880 (Natriuretic peptide). NT-proBNP is the more commonly ordered test and has different reference ranges than BNP. The CPT code is the same for both. Documenting which peptide was ordered and the result value supports medical necessity for HF diagnosis confirmation.

🧾 HCPCS

HCPCS CodeDescriptionTypical Use / Notes
J1250Injection, dobutamine HCl, per 250 mgAcute decompensated HFrEF; inotropic support; IV infusion in hospital/outpatient
J1265Injection, dopamine HCl, 40 mgCardiogenic shock, low-output HF; renal dose dopamine (low dose)
J1952Injection, milrinone lactate, 5 mgPDE-3 inhibitor for acute HF, bridge therapy; IV infusion
J1644Injection, heparin sodium, per 1000 USP unitsHF with AF, DVT/PE prophylaxis, LVAD/device thrombosis prevention
C9604CRT-D device (cardiac resynchronization therapy with defibrillator)HFrEF with LBBB, LVEF ≤ 35%; biventricular pacing + ICD; per implant
C1721Cardioverter-defibrillator, dual chamber (implantable)ICD for HFrEF primary prevention (LVEF ≤ 35%)
C1722Cardioverter-defibrillator, single chamber (implantable)Single-chamber ICD; appropriate for many HFrEF patients
Q0478VAD component (non-pump)LVAD system components (controllers, accessories) billed separately from implant
J3490Unclassified drug (sacubitril/valsartan, vericiguat when no specific J-code)Entresto (sacubitril/valsartan) — HFrEF GDMT; Medicare Part D (oral); use J3490 for infusion formulations only. Vericiguat (Verquvo) similarly billed under J3490 or Part D NDC.
J2325Injection, nesiritide, 0.1 mgNatrecor (BNP analog vasodilator) for acute decompensated HF
J1940Injection, furosemide, 20 mgIV loop diuretic for acute HF/decompensation; most commonly billed HF drug
J1939Injection, bumetanide, 0.5 mgIV loop diuretic for acute HF/decompensation; verify current HCPCS/NDC billing units
📝 Coder Note

Part D vs Medical Benefit: Sacubitril/valsartan (Entresto) and vericiguat (Verquvo) are oral medications covered under Medicare Part D, not the Part B medical benefit. They are not billed with HCPCS J-codes in the outpatient Part B setting. HCPCS J3490 applies only when a drug lacks its own J-code and is administered in a provider office or infusion center setting. For these oral HF agents, ensure the Part D formulary coverage status is verified for Medicare patients. Pegloticase (J2503) and ceftazidime (J0714) are not applicable to HF care.

📚 AHA Coding Clinic

ReferenceTopicGuidance Summary
AHA Coding Clinic, 3Q 2023, “Acute on Chronic Right Heart Failure and Diastolic Heart Failure with Improved/Recovered Ejection Fraction”; AHA Coding Clinic, 3Q 2020, “Heart Failure with Recovered Ejection Fraction”HFimpEF: Heart Failure with Improved EFHeart failure with improved ejection fraction (HFimpEF) and heart failure with recovered ejection fraction (HFrecEF) are used interchangeably. Coding Clinic assigns a code from subcategory I50.3-, Diastolic (congestive) heart failure, for these terms; for example, chronic heart failure with recovered or improved EF is coded I50.32. Subcategory I50.3- includes heart failure with normal ejection fraction and heart failure with preserved ejection fraction [HFpEF].
AHA Coding Clinic, 1Q 2017, “Hypertension with Congestive Heart Failure”; ICD-10-CM Official Guidelines for Coding and Reporting FY 2027, Section I.C.9.a.1HTN + HF Causal AssumptionAssign I11.0, Hypertensive heart disease with heart failure, along with the appropriate code from category I50 to identify the type of heart failure. The classification presumes a causal relationship between hypertension and heart involvement unless the provider documents that the conditions are unrelated; in that case, code them separately with I10 (or I15.-) and sequence according to the circumstances of the encounter.
ICD-10-CM Tabular List FY 2027, subcategory I26.0- and code I27.81 Excludes1 noteAcute cor pulmonale with PEPulmonary embolism with acute cor pulmonale is classified to subcategory I26.0-: I26.01 septic, I26.02 saddle, I26.03 cement, I26.04 fat, and I26.09 other pulmonary embolism with acute cor pulmonale (which includes acute cor pulmonale NOS). Code I27.81, Cor pulmonale (chronic), has an Excludes1 note for acute cor pulmonale (I26.0-).
AHA Coding Clinic, 4Q 2017, “Other Heart Failure”; ICD-10-CM Tabular List FY 2027, code I50.84End-stage HF (I50.84)Code I50.84, End stage heart failure, was created effective October 1, 2017. Coding Clinic explains that end stage heart failure falls into stage D of the American College of Cardiology/American Heart Association classification, and the FY 2027 Tabular lists Stage D heart failure as an inclusion term at I50.84. Code also the type of heart failure as systolic, diastolic, or combined, if known (I50.2-I50.43).
AHA Coding Clinic for ICD-9-CM, 1Q 2009, “Diastolic or Systolic Dysfunction without Heart Failure”; ICD-10-CM Alphabetic Index FY 2027, Dysfunction, ventricularDiastolic dysfunction without heart failureDiastolic or systolic dysfunction is not coded the same as heart failure. It is not appropriate to assume a patient is in heart failure when only “diastolic dysfunction” or “systolic dysfunction” is documented. This advice was issued under ICD-9-CM; in the FY 2027 Alphabetic Index, Dysfunction, ventricular leads to I51.9, with the subterm with congestive heart failure leading to I50.9. Code a type of heart failure from category I50 only when the provider documents heart failure.
ICD-10-CM Official Guidelines for Coding and Reporting FY 2027, Section I.C.9.a.3; ICD-10-CM Tabular List FY 2027, codes I13.0 and I13.2I13.x Sequencing RulesCategory I13 codes are combination codes that include hypertension, heart disease, and chronic kidney disease. If heart failure is present, assign an additional code from category I50 to identify the type of heart failure, and use a code from category N18 as a secondary code to identify the CKD stage (I13.0 with N18.1-N18.4 or N18.9; I13.2 with N18.5 or N18.6). Category N18 has a code first note for hypertensive chronic kidney disease (I12.-, I13.-), so the I13 code is sequenced before the N18 code.

💰 HCC / Risk Adjustment

Heart failure HCCs in V28 are set by acuity and severity, not by systolic versus diastolic type. Mappings below follow the 2024 CMS-HCC model (commonly called V28), which CMS uses at 100 percent for non-PACE Medicare Advantage risk scores and continued for CY 2027, and the CMS 2027 Initial ICD-10-CM Mappings. Coefficients vary by enrollee segment and payer, so this guide does not quote RAF weights; check the current CMS model software. Hierarchies are applied by CMS after coding: code every documented, supported condition.

ICD-10-CM Code(s)DescriptionV28 HCCCoding / Documentation Notes
I50.84End-stage heart failureHCC 222 — End-Stage Heart FailureCode only when the provider documents end-stage heart failure; also code the HF type (Tabular note)
Z95.811, Z95.812Presence of heart assist device / fully implantable artificial heartHCC 223 — Heart Failure with Heart Assist Device/Artificial HeartHCC 222 and 223 share one coefficient (CMS constraint)
I50.23, I50.33, I50.43Acute on chronic systolic, diastolic, or combined HFHCC 224 — Acute on Chronic Heart FailureUsually documented during an inpatient stay or ED visit
I50.21, I50.31, I50.41, I50.811, I50.813Acute systolic, diastolic, combined, or right HFHCC 225 — Acute Heart Failure (Excludes Acute on Chronic)Do not carry “acute” into later office notes when the patient is stable
I50.22, I50.32, I50.42, I50.20, I50.30, I50.40, I50.9, I50.1, I50.810, I50.812, I50.814, I50.82, I50.83, I50.89Chronic, unspecified, left ventricular, other right, high-output, biventricular, and other HFHCC 226 — Heart Failure, Except End-Stage and AcuteHFrEF indexes to systolic HF and HFpEF to diastolic HF (FY 2027 Index)
I11.0, I13.0, I09.81Hypertensive heart disease with HF; hypertensive heart and CKD with HF; rheumatic HFHCC 226Also code the HF type (I50.-); I13.2 maps to HCC 226 and HCC 326
I27.81, I27.89, I27.0, I27.2-Chronic cor pulmonale; other pulmonary heart disease; pulmonary hypertensionHCC 226Same HCC as chronic HF, so it adds nothing when HF is also coded
I27.82Chronic pulmonary embolismHCC 267 — Deep Vein Thrombosis and Pulmonary EmbolismNot a heart failure HCC
I51.4, I51.5Myocarditis, unspecified; myocardial degenerationHCC 227 — Cardiomyopathy/MyocarditisDropped when any HF HCC (221–226) is present
I51.7, I51.81, I51.89, I51.9Cardiomegaly; Takotsubo syndrome; other and unspecified heart diseaseNo V28 payment HCCCode when documented; does not substitute for an HF diagnosis
🛡️ Audit Alert — Hierarchy and Constraint

In V28, HCC 224 drops 225, 226, and 227; HCC 225 drops 226 and 227; HCC 226 drops 227; HCC 221 (heart transplant status/complications) and 222 drop all lower heart failure HCCs. CMS constrained HCCs 224, 225, and 226 to one coefficient, so acuity does not change the risk score among them. Acuity still must match the clinical picture and the date of service: “acute on chronic” copied forward into stable office follow-ups is a RADV risk. Heart failure also triggers disease interactions with diabetes (HCCs 35–38), chronic lung disorders (276–280), kidney disease (326–329), and specified arrhythmias (238); CMS calculates these automatically.

Sources: CMS 2027 Initial ICD-10-CM Mappings (2024 CMS-HCC model, V28); CMS CY 2024 Rate Announcement, Attachment VI (hierarchies, constraints, interactions); FY 2027 ICD-10-CM Tabular List, Index, and Official Guidelines Section I.C.9. Verified November 3, 2026.

✍️ CDI Query Templates

All queries below follow AHIMA/ACDIS compliant query standards: non-leading, multiple-choice format with a clinical indicator summary and “other/unable to determine” options.

Query ScenarioClinical TriggerQuery Template (Abbreviated)
HF Type Unspecified — Systolic vs. DiastolicDocumentation states “CHF” or “heart failure” without type; echocardiogram in chart“Based on the clinical documentation, echocardiography findings (LVEF ___%), and clinical presentation, can you clarify the type of heart failure? Options: (a) Systolic heart failure/HFrEF (LVEF <40%), (b) Diastolic heart failure/HFpEF (LVEF ≥50%), (c) Combined systolic and diastolic HF, (d) Other: ___, (e) Unable to determine.”
Acuity Not Documented — Acute vs. ChronicHF documented but no designation of acute, chronic, or acute-on-chronic; patient admitted for HF decompensation“The patient was admitted with heart failure requiring IV diuresis. Can you clarify the acuity of the heart failure? Options: (a) Acute heart failure (new onset/single episode), (b) Chronic heart failure (stable, ongoing), (c) Acute on chronic heart failure (known chronic HF with acute decompensation), (d) Other: ___, (e) Unable to determine.”
HFpEF vs HFrEF from EF DocumentationEcho LVEF value present in chart but physician’s assessment does not specify HF type“The echocardiogram dated [date] documents an LVEF of ___%. The patient carries a diagnosis of heart failure. Based on the documented EF and clinical findings, can you specify: (a) HFrEF (systolic HF, LVEF <40%), (b) HFpEF (diastolic HF, LVEF ≥50%), (c) HFmrEF (mildly reduced EF, LVEF 41-49%), (d) Other: ___, (e) Unable to determine.”
Hypertension + Heart Failure — Causal LinkagePatient has both hypertension (on antihypertensives) and heart failure documented, coded separately as I10 + I50.x“The patient has documented diagnoses of both hypertension and heart failure. Is the heart failure causally related to the hypertension (i.e., hypertensive heart disease with heart failure)? Options: (a) Yes — hypertensive heart disease with heart failure (I11.0), (b) No — heart failure is due to another etiology: ___, (c) Unable to determine.”
Heart Failure + CKD + HTN — I13.x SequencingAll three conditions documented; coded separately or only I11.0 used without N18.x“The patient has documented hypertension, heart failure, and CKD. Are all three conditions present and causally related? If so, please confirm: (a) The CKD stage (N18.1–N18.5/N18.6), (b) Whether dialysis is present (Z99.2), and (c) Confirm hypertensive heart and chronic kidney disease with heart failure for combination code I13.0 or I13.2. Or (d) Other etiology for HF: ___, (e) Unable to determine.”
Cor Pulmonale EtiologyRight heart failure or RV enlargement documented; pulmonary disease also present (COPD, ILD, PAH)“The patient has right-sided heart failure with documented pulmonary disease ([COPD/ILD/PAH]). Is the right heart failure secondary to pulmonary hypertension from the pulmonary disease (cor pulmonale)? Options: (a) Yes — chronic cor pulmonale (I27.81) due to [COPD/ILD/other], (b) Right HF secondary to left heart failure (I50.814), (c) Right HF, other etiology: ___, (d) Unable to determine.”
End-Stage / Stage D DocumentationPatient has LVAD, on transplant list, in cardiac hospice, or has NYHA Class IV refractory symptoms“Clinical indicators (e.g., LVAD implant, transplant candidacy evaluation, NYHA Class IV refractory to maximal GDMT) suggest advanced heart failure. Can you document whether this patient has end-stage (Stage D) heart failure? Options: (a) Yes — end-stage heart failure (I50.84), (b) Advanced HF but not end-stage at this time, (c) Other: ___, (d) Unable to determine.”
Right HFpEF vs Right HFrEF (New FY2024 Codes)Right-sided HF documented; echo includes RV and LV EF data; FY2024+ encounter“The patient has documented right heart failure. The echocardiogram shows [preserved/reduced] ejection fraction. Can you confirm: (a) Right heart failure with preserved EF (I50.A1x), (b) Right heart failure with reduced EF (I50.A2x), (c) Right HF, EF status not determinable, (d) Other: ___, (e) Unable to determine.”
💬 CDI Query Trigger

High-yield HF query opportunity: Any inpatient encounter with a principal diagnosis of I50.9 (HF unspecified) should trigger a concurrent CDI query for both type and acuity. A successful query converting I50.9 to I50.23 (acute-on-chronic systolic HF) documents the correct V28 HCC (HCC 224 rather than 226; CMS constrains both to one coefficient) and may also affect the MS-DRG assignment — DRG 291 (HF w/ MCC) vs DRG 292 (HF w/ CC) vs DRG 293 (HF without CC/MCC). The difference in geometric mean LOS and expected payment between DRG 291 and 293 can exceed $3,000 per case.

🧑‍⚕️ Treatments (Clinical)

Acute Decompensated HF (ADHF) Management

Per 2022 AHA/ACC/HFSA Heart Failure Guidelines:

  • Diuresis: IV loop diuretics (furosemide, bumetanide, torsemide) for volume overload. DOSE trial evidence supports higher-dose diuresis for decongestion. Monitor renal function, electrolytes.
  • Vasodilators: IV nitroglycerin or nesiritide for afterload reduction in acute HFrEF or acute cardiogenic pulmonary edema with hypertension.
  • Inotropes: Dobutamine or milrinone for cardiogenic shock or low-output state. Reserved for hemodynamically compromised patients (systolic BP <90 mmHg, low CO).
  • Oxygen/Ventilatory Support: Non-invasive positive pressure ventilation (CPAP/BiPAP) for cardiogenic pulmonary edema; intubation for refractory hypoxia.
  • Mechanical Circulatory Support (MCS): Impella (CPT 33990–33993) or IABP for cardiogenic shock bridging. VA-ECMO (CPT 33960) for refractory shock.

Chronic Stable HF Management (GDMT)

  • HFrEF (LVEF < 40%): Four-pillar GDMT — ARNI/ACEi/ARB + beta-blocker + MRA + SGLT2 inhibitor. Target doses per guidelines. Avoid NSAIDs, non-dihydropyridine CCBs, most antiarrhythmics.
  • HFpEF (LVEF ≥ 50%): SGLT2 inhibitors (Class IIa recommendation per 2022 guidelines), diuretics for congestion, treat underlying comorbidities (HTN, AF, obesity, DM). Limited mortality-benefit drugs specific to HFpEF.
  • Device Therapy: ICD for primary prevention (LVEF ≤ 35%, NYHA II–III, on GDMT ≥ 3 months). CRT-D for LVEF ≤ 35% with LBBB (QRS ≥ 150 ms). Wearable defibrillator (LifeVest) as bridge after new HFrEF diagnosis.
  • Cardiac Rehabilitation: Class I recommendation for stable ambulatory HF patients. Improves functional capacity and quality of life.
  • Sodium Restriction: <2–3 g/day. Fluid restriction (<1.5–2 L/day) for dilutional hyponatremia or advanced HF.

Advanced HF (Stage D) Therapies

  • LVAD (Destination Therapy or BTT): HeartMate 3 demonstrated superiority in MOMENTUM 3 trial. Continuous-flow devices; requires lifelong anticoagulation, battery management, driveline exit site care.
  • Heart Transplantation: Gold standard for end-stage HF; limited by donor availability. Requires immunosuppression. Post-transplant status: Z94.1.
  • Palliative Care / Hospice: Appropriate for end-stage HF patients declining advanced therapies. Symptom management focus.

Cor Pulmonale (Chronic) Treatment

  • Treat the Underlying Pulmonary Disease: COPD — bronchodilators, inhaled steroids, smoking cessation, pulmonary rehabilitation, supplemental oxygen (improves pulmonary hypertension and RV function).
  • Long-term Oxygen Therapy (LTOT): Reduces pulmonary vascular resistance, improves exercise tolerance, and slows progression of cor pulmonale in hypoxic COPD patients.
  • Pulmonary Vasodilators: For PAH-related cor pulmonale — sildenafil (PDE-5 inhibitor), riociguat (sGC stimulator), prostacyclin analogs (epoprostenol, treprostinil), endothelin receptor antagonists (bosentan). Not routinely used for COPD-related cor pulmonale (may worsen V/Q mismatch).
  • Diuretics: For right-sided congestion (JVD, ascites, peripheral edema). Avoid over-diuresis in RHF (reduces RV preload and may worsen low CO).
  • Anticoagulation: For CTEPH (I27.82) — lifelong anticoagulation; pulmonary endarterectomy (PEA) for operable CTEPH; riociguat or balloon pulmonary angioplasty for inoperable CTEPH.

🎓 Patient Education / Summary

Summary for Healthcare Professionals

Heart failure is a major chronic disease affecting approximately 6.7 million Americans with an annual direct cost exceeding $30 billion. Optimal ICD-10-CM coding requires capturing three dimensions of specificity: type (systolic/diastolic/combined/right-sided), acuity (acute/chronic/acute-on-chronic), and etiology (hypertensive, cardiorenal, rheumatic, or idiopathic). Acuity and severity determine the V28 HCC; all three dimensions affect code assignment, MS-DRG, and quality metric attribution.

Cor pulmonale — right heart failure from pulmonary disease — is frequently under-documented and undercoded. The distinction between I27.81 (chronic cor pulmonale, HCC 226) and I50.81x (right HF codes) has both clinical and reimbursement significance. Always document the pulmonary etiology when right heart failure is present in a patient with significant lung disease.

Key Takeaways for CDI Teams

  • Never leave “CHF” unspecified — always query for type and acuity
  • When HTN and HF coexist: use I11.0 (or I13.x for CKD triad), not I10 + I50.x
  • Acute-on-chronic HF (I50.x3 series) = HCC 224; acute = HCC 225; chronic or unspecified = HCC 226 (one constrained coefficient)
  • End-stage HF (I50.84) requires explicit physician documentation
  • FY2024 new codes I50.A1x/A2x: right HF with EF specification — query when echo available
  • Cor pulmonale (I27.81) vs right HF (I50.81x) — document pulmonary etiology clearly
  • HFimpEF: code the current EF state, not the historical nadir
  • I51.81 (diastolic dysfunction) ≠ HFpEF — symptoms required for HF diagnosis
  • BNP/NT-proBNP elevation alone does not establish HF — physician must document clinical HF diagnosis

Patient-Facing Education Points

  • Daily weight monitoring: Weigh every morning after urinating; notify provider for >2–3 lb gain in 1–2 days (early sign of fluid accumulation)
  • Sodium restriction: Limit sodium to <2,000–2,300 mg/day; avoid processed foods, canned soups, fast food
  • Fluid restriction: Limit total fluid intake to 1.5–2 L/day if advised by physician
  • Medication adherence: Never stop heart failure medications without physician guidance; some medications (beta-blockers) may worsen symptoms initially but improve long-term outcomes
  • Activity: Participate in cardiac rehabilitation; gradually increase walking; avoid extreme heat/cold
  • Warning signs requiring emergency care: Sudden severe shortness of breath, coughing pink/frothy sputum, inability to lie flat, rapid weight gain, extreme fatigue, syncope
  • Cor pulmonale patients: Use supplemental oxygen as prescribed; smoking cessation is the single most effective intervention for COPD-related cor pulmonale
  • Follow-up: Attend all scheduled cardiology and primary care appointments; TCM (CPT 99495/99496) support available within 7–14 days of hospital discharge reduces readmission risk

MS-DRG Quick Reference (FY2026)

MS-DRGDescriptionGeometric Mean LOS (approx.)Notes
291Heart Failure & Shock with MCC~4.8 daysHighest payment; requires MCC (e.g., acute renal failure, sepsis, ventilator)
292Heart Failure & Shock with CC~3.4 daysModerate complexity; CC required (e.g., atrial fibrillation, DM, COPD)
293Heart Failure & Shock without CC/MCC~2.3 daysLowest weight; query for CC/MCC to optimize DRG

For additional coding resources, coding education, and CDI query tools, visit CCO Clinical Documentation Guides and the CMS FY2026 ICD-10-CM Official Guidelines.


About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)

Ready to turn this knowledge into a credential?

These Clinical Documentation Guides are a free companion to CCO’s paid training programs. Browse our full CCO Course, Blitz & Practice Exam Catalog — every core course, review blitz, practice exam, textbook, and free resource in one place — and find the perfect next step for your coding career.

CCO Hero

Know someone starting a medical coding career?

Share your personal CCO link. Your friend saves 20% on their first course or practice exam of $100 or more, and you earn 5% cash on their first enrollment over $100.

Become a CCO Hero
Photo of author

CCO Certified Professionals

The CCO Certified Professionals team brings together experienced, credentialed medical coders, CDI specialists, and clinical documentation experts with decades of combined expertise in inpatient, outpatient, and risk-adjustment coding. Every Clinical Documentation Guide is built and reviewed by certified instructors who teach, code, and audit in the field every day. Content is verified against current ICD-10-CM, AHA Coding Clinic, and CMS guidance.

Leave a Comment

Clinical Doc Guides

⚊